hypophosphatemia%20-and-%20hyperphosphatemia
HYPOPHOSPHATEMIA & HYPERPHOSPHATEMIA

Hypophosphatemia is an electrolyte imbalance where there is a decrease in the serum phosphate level that is less than the normal range.

It is recognized most often in critically-ill patients, decompensated diabetics, alcoholics or other malnourished persons, and acute infectious or pulmonary disorders.

It may be transient and reflect intracellular shift with minimal clinical consequences.

Hyperphosphatemia is an electrolyte disturbance in which an increase in the serum phosphate level of more than the normal range is present.

Most symptoms of acute hyperphosphatemia are due to secondary hypocalcemia.

The significant level of hyperphosphatemia in adults is >6 mg/dL.

Monitoring

Monitoring of Hyperphosphatemia in Chronic Kidney Disease (CKD) Patients
  • Monitoring of serum phosphate in CKD patients should start in patients w/ grade 3 CKD
    • Frequency of monitoring will be based on the presence & magnitude of abnormalities & the rate of progression of the disease
  • Monitoring of serum phosphate intervals may be as followed:
    • Every 6-12 months in patients w/ grade 3 CKD
    • Every 3-6 months in patients w/ grade 4 CKD
    • Every 1-3 months in patients w/ grade 5 CKD
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 17 Oct 2017

Patients with type 2 diabetes (T2D) may not necessarily have lower trabecular bone scores (TBS) than nondiabetics, a finding that contrasts with that of previous research, according to a study published in a poster at the recent meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017), held in Kuala Lumpur, Malaysia.